Shares of Bio-Techne Corp. TECH slipped 1.78% to $59.98 Tuesday, on what proved to be an all-around favorable trading session ...

Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, ...

Corporation announced further advancements in its ongoing strategy to bring translational discoveries to patient care by ...

Bio-Techne Corporation (NASDAQ: TECH) today announced further advancements in its ongoing strategy to bring translational discoveries to patient care by leveraging RNAscope technology to address unmet ...

Equities research analysts at Evercore ISI assumed coverage on shares of Bio-Techne (NASDAQ:TECH – Get Free Report) in a ...

Detailed price information for Bio-Techne Corp (TECH-Q) from The Globe and Mail including charting and trades.

The stock's fall snapped a three-day winning streak.

Learn more about whether Repligen Corporation or Bio-Techne Corporation is a better investment based on AAII's A+ Investor ...

Fintel reports that on March 18, 2025, Evercore ISI Group initiated coverage of Bio-Techne (NasdaqGS:TECH) with a Outperform ...

The investment bank said Bio-Techne is a premium growth asset with a strong core business and growth verticals.

Evercore ISI initiated coverage of Bio-Techne (TECH) with an Outperform rating and $75 price target The firm believes that current volatility ...

Bio-Techne Corporation ( NASDAQ:TECH ) shareholders might be concerned after seeing the share price drop 17% in ...